ITGA6 and neoplasm: Next, the potency of ITGA6 as a non-invasive biomarker was further confirmed through ROC analysis, with an AUC of 0.817, demonstrating robust diagnostic power for distinguishing non-tumor conditions from HCC (Figure 5b).